facebook instagram twitter linkedin youtube flickr

All the news

Inject4Pain is Bluepharma’s new project co-financed by Portugal 2020

10.03.2020 in Bluepharma

The main goal of the project is to increase Bluepharma´s differentiation and international competitiveness by investing on Research and Development


Inject4Pain is Bluepharma’s new project co-financed by Portugal 2020. The project entitled New biomaterials and its application in Long Acting Injectable drug formulations has a duration of 24 months and will be concluded in February 2022.

The main goal of the project is to increase Bluepharma´s differentiation and international competitiveness by investing on Research and Development. The project proceeds Bluepharma’s strategy of technological differentiation initiated in 2017 with the development of lipid-based complex injectables. These products are value added medicines with a significant market need since few pharmaceutical companies have the capacity and scientific-technical skills to develop and manufacture these products.

Inject4Pain will also allow the strengthening of the collaboration between Bluepharma and the University of Coimbra with whom the Sponsor cooperated in R&D projects in the last years due to its large experience in the synthesis of new polymers with application in the development of new pharmaceutical dosage forms.